Domestic ViolenceIPVNCT07405528
Camouflaged WeChat-based Intervention for Abused Women
A study testing WOMEN Health programme in people with Domestic Violence and Mental Health Wellness 1, run by The University of Hong Kong at 1 site in China.
Trial summary
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and… Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Domestic Violence, Mental Health Wellness 1
- What is being tested?
- WOMEN Health programme
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 86 participants
- Where
- 1 siteChina
- Study dates
- Feb 2026to Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Chinese-speaking (Mandarin or Cantonese)
- women aged 18 to 45 years
- originally from mainland China and have moved to Hong Kong for at least one year
- screened positive for IPV during heterosexual relationships in the past year
- have a smartphone with WeChat installed
- with no plans to move outside Hong Kong in the next one year
Who cannot join
- unwilling to provide informed consent
- severe chronic diseases (e.g., cancer, heart failure, kidney failure, chronic obstructive pulmonary disease, and HIV/AIDS)
- currently experience severe IPV (identified using the revised 11-item Danger Assessment)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
The University of Hong Kong
Hong Kong
Quanlei LI, PhD, +852 39177577, qli1@hku.hk
About this study
Official title: Camouflaged WeChat Mini-program-based Intervention for Women Victims of Intimate Partner Violence: Protocol for a Pilot Mixed Methods Study
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. The overall objective of this pilot mixed methods study is to determine the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
Read the detailed description
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. Previous studies in Hong Kong and the United States provided evidence on IPV interventions among Chinese abused women; however, there is a scarcity of evidence on the use of mHealth for abused women while fully considering their safety studies on mobile technology for Chinese immigrant women victims are limited, and there lacks safe, low-cost, and evidence-based mHealth interventions for empowering and supporting women victims who immigrate to Hong Kong and face more vulnerabilities and needs. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
This pilot mixed methods study will adopt the randomized, wait-list controlled trial with two groups (1:1 ratio), followed by in-depth interviews with participants in the WOMEN Health programme group at post-intervention. It will evaluate feasibility and acceptability as the primary outcomes and compare scores changes after 12 weeks interventions between Chinese immigrant women who are screened positive for IPV randomly assigned to receiving genuine IPV intervention and disguised healthy lifestyle intervention, and Chinese immigrant women who are screened positive for IPV in a control procedure. The wait-list control group will also receive the WOMEN Health programme after the intervention group completed the programme.
- Conditions
- Domestic Violence, Mental Health Wellness 1
- Being tested
- WOMEN Health programme, Wait-list control group
- Keywords
- Domestic Violence, Intimate partner violence, mHealth intervention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WOMEN Health programmeBehavioural
(i) Empowerment (IPV information, ie, 30-min one-to-one interview, WeChat mini-program); (ii) Telephone social support (ie, weekly calls); (ⅲ) Healthy lifestyle intervention (ie, healthy lifestyle information and discussion)
Wait-list control groupBehavioural
(i) Healthy lifestyle intervention (ie, discussion and weekly calls for body weight)
| Study group | Role | What they receive |
|---|---|---|
| WOMEN Health group | Experimental | The WOMEN Health programme Receives: Behavioral: WOMEN Health programme |
| Wait-list control group | Active comparator | Healthy lifestyle intervention Receives: Behavioral: Wait-list control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility and acceptability of the WOMEN Health programme
Feasibility and acceptability will be assessed using a 12-item self-developed questionnaire. Items are rated on a 5-point Likert scale (1-5), with higher scores indicating greater acceptability, satisfaction, and usefulness.
Measured: Week 12
Secondary outcomes (5)
Changes in depressive symptoms
Depressive symptoms will be assessed using the Chinese version of the Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire measuring depressive symptoms experienced over the past two weeks. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms.
Measured: Baseline and Week 12
Changes in quality of life
Quality of life will be assessed using the Chinese version of the 12-Item Short Form Health Survey, version 2 (SF-12v2), which measures physical and mental health status. Physical Component Summary (PCS) and Mental Component Summary (MCS) scores range from 0 to 100, with higher scores indicating better quality of life.
Measured: Baseline and Week 12
Changes in intimate partner violence (IPV)
Intimate partner violence will be assessed using the Chinese version of the Revised Conflict Tactics Scales (CTS2), which measures the frequency and severity of psychological aggression, physical assault, sexual coercion, and injury within intimate relationships. Higher scores indicate greater exposure to intimate partner violence.
Measured: Baseline and Week 12
Changes in Body Mass Index (BMI)
Body weight will be self-measured by participants at home in the morning under fasting conditions, wearing light clothing and without shoes. Height will be measured at baseline using a wall-mounted stadiometer. BMI will be calculated as body weight in kilograms divided by height in meters squared (kg/m²) and categorized according to the World Health Organization (WHO) recommendations for Asian populations.
Measured: Baseline and up to 12 weeks
Changes in healthy behaviors
Healthy lifestyle behaviors, including physical activity and dietary behaviors, will be documented by self-report data
Measured: Baseline and Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2026
- Study startFeb 2026 (estimated)
- Primary completionSep 2026 (estimated)
- Study completionFeb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (12)Papers the sponsor has linked to this study.
- Other trials for Domestic ViolenceStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 86 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07405528
- Sponsor's protocol ID
- 22232811
- Other IDs
- 22232811
- Acronym
- IPV
- Status last verified
- Jan 2026
- First submitted
- 29 Dec 2025
- Last updated
- 12 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Draughon Moret J, Todd A, Rose L, Pollitt E, Anderson J. Mobile Phone Apps for Intimate Partner and Sexual Violence Prevention and Response: Systematic Search on App Stores. JMIR Form Res. 2022 Feb 8;6(2):e28959. doi: 10.2196/28959.
PubMed 35133285Glass NE, Clough A, Messing JT, Bloom T, Brown ML, Eden KB, Campbell JC, Gielen A, Laughon K, Grace KT, Turner RM, Alvarez C, Case J, Barnes-Hoyt J, Alhusen J, Hanson GC, Perrin NA. Longitudinal Impact of the myPlan App on Health and Safety Among College Women Experiencing Partner Violence. J Interpers Violence. 2022 Jul;37(13-14):NP11436-NP11459. doi: 10.1177/0886260521991880. Epub 2021 Feb 12.
PubMed 33576291Lin Z, Cheng L, Han X, Wang H, Liao Y, Guo L, Shi J, Fan B, Teopiz KM, Jawad MY, Zhang H, Chen Y, Lu C, McIntyre RS. The Effect of Internet-Based Cognitive Behavioral Therapy on Major Depressive Disorder: Randomized Controlled Trial. J Med Internet Res. 2023 Sep 22;25:e42786. doi: 10.2196/42786.
PubMed 37738092Chen D, Zhang H, Wu J, Xue E, Guo P, Tang L, Shao J, Cui N, Wang X, Chen L, Ye Z. Effects of an Individualized mHealth-Based Intervention on Health Behavior Change and Cardiovascular Risk Among People With Metabolic Syndrome Based on the Behavior Change Wheel: Quasi-Experimental Study. J Med Internet Res. 2023 Nov 29;25:e49257. doi: 10.2196/49257.
PubMed 38019579Sumra M, Asghar S, Khan KS, Fernandez-Luna JM, Huete JF, Bueno-Cavanillas A. Smartphone Apps for Domestic Violence Prevention: A Systematic Review. Int J Environ Res Public Health. 2023 Mar 23;20(7):5246. doi: 10.3390/ijerph20075246.
PubMed 37047862Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.
PubMed 17872937Li Y, Rhee H, Bullock LFC, McCaw B, Bloom T. Self-Compassion, Health, and Empowerment: A Pilot Randomized Controlled Trial for Chinese Immigrant Women Experiencing Intimate Partner Violence. J Interpers Violence. 2024 Apr;39(7-8):1571-1595. doi: 10.1177/08862605231207624. Epub 2023 Oct 30.
PubMed 37902465Chan KL. Correlates of wife assault in Hong Kong Chinese families. Violence Vict. 2004 Apr;19(2):189-201. doi: 10.1891/vivi.19.2.189.64104.
PubMed 15384454Barbara MB, S. SM, H. PW. Validating the Beck Depression Inventory-II for Hong Kong Community Adolescents. International Journal of Testing. 2004;4(3):199-216. doi:10.1207/s15327574ijt0403_1
Tiwari A, Leung WC, Leung TW, Humphreys J, Parker B, Ho PC. A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong. BJOG. 2005 Sep;112(9):1249-56. doi: 10.1111/j.1471-0528.2005.00709.x.
PubMed 16101604Tiwari A, Fong DYT, Yuen FKH, Fung HYK, Pang POY, Wong JYH. Purpose-built intervention for mental health of Mainland Chinese immigrant women survivors of intimate partner violence: a randomised controlled trial (abridged secondary publication). Hong Kong Med J. 2020 Dec;26 Suppl 8(6):7-9. No abstract available.
PubMed 33504670Broadhurst R, Bouhours B, Bacon-Shone J. Hong Kong the international violence against women survey: final report of the 2006 Hong Kong IVAWS. 2012. doi.org/10.2139/ssrn.2076994.
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Camouflaged WeChat Mini-program-based Intervention for Women Victims of Intimate Partner Violence: Protocol for a Pilot Mixed Methods Study
- ClinicalTrials.gov ID
- NCT07405528
- Acronym / sponsor ID
- IPV / 22232811
- Conditions
- Domestic Violence, Mental Health Wellness 1
- Keywords
- Domestic Violence, Intimate partner violence, mHealth intervention
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 86 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Study start
- Feb 2026 (estimated)
- Primary completion
- Sep 2026 (estimated)
- Study completion
- Feb 2027 (estimated)
- First posted
- 12 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. The overall objective of this pilot mixed methods study is to determine the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
Detailed description
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. Previous studies in Hong Kong and the United States provided evidence on IPV interventions among Chinese abused women; however, there is a scarcity of evidence on the use of mHealth for abused women while fully considering their safety studies on mobile technology for Chinese immigrant women victims are limited, and there lacks safe, low-cost, and evidence-based mHealth interventions for empowering and supporting women victims who immigrate to Hong Kong and face more vulnerabilities and needs. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
This pilot mixed methods study will adopt the randomized, wait-list controlled trial with two groups (1:1 ratio), followed by in-depth interviews with participants in the WOMEN Health programme group at post-intervention. It will evaluate feasibility and acceptability as the primary outcomes and compare scores changes after 12 weeks interventions between Chinese immigrant women who are screened positive for IPV randomly assigned to receiving genuine IPV intervention and disguised healthy lifestyle intervention, and Chinese immigrant women who are screened positive for IPV in a control procedure. The wait-list control group will also receive the WOMEN Health programme after the intervention group completed the programme.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| WOMEN Health group | Experimental | Behavioral: WOMEN Health programmeThe WOMEN Health programme |
| Wait-list control group | Active comparator | Behavioral: Wait-list control groupHealthy lifestyle intervention |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Chinese-speaking (Mandarin or Cantonese)
- women aged 18 to 45 years
- originally from mainland China and have moved to Hong Kong for at least one year
- screened positive for IPV during heterosexual relationships in the past year
- have a smartphone with WeChat installed
Key exclusion criteria (3 listed)
- unwilling to provide informed consent
- severe chronic diseases (e.g., cancer, heart failure, kidney failure, chronic obstructive pulmonary disease, and HIV/AIDS)
- currently experience severe IPV (identified using the revised 11-item Danger Assessment)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WOMEN Health programme(i) Empowerment (IPV information, ie, 30-min one-to-one interview, WeChat mini-program); (ii) Telephone social support (ie, weekly calls); (ⅲ) Healthy lifestyle intervention (ie, healthy lifestyle information and discussion) | Behavioural | WOMEN Health group |
| Wait-list control group(i) Healthy lifestyle intervention (ie, discussion and weekly calls for body weight) | Behavioural | Wait-list control group |
Primary outcome
Feasibility and acceptability of the WOMEN Health programme
Time frame: Week 12
Feasibility and acceptability will be assessed using a 12-item self-developed questionnaire. Items are rated on a 5-point Likert scale (1-5), with higher scores indicating greater acceptability, satisfaction, and usefulness.
5 secondary outcomes
Changes in depressive symptoms
Time frame: Baseline and Week 12
Changes in quality of life
Time frame: Baseline and Week 12
Changes in intimate partner violence (IPV)
Time frame: Baseline and Week 12
Changes in Body Mass Index (BMI)
Time frame: Baseline and up to 12 weeks
Changes in healthy behaviors
Time frame: Baseline and Week 12
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2026.
- Results publication: PubMed 35133285Draughon Moret J, Todd A, Rose L, Pollitt E, Anderson J. Mobile Phone Apps for Intimate Partner and Sexual Violence Prevention and Response: Systematic Search on App Stores. JMIR Form Res. 2022 Feb 8;6(2):e28959. doi: 10.2196/28959.
- Results publication: PubMed 33576291Glass NE, Clough A, Messing JT, Bloom T, Brown ML, Eden KB, Campbell JC, Gielen A, Laughon K, Grace KT, Turner RM, Alvarez C, Case J, Barnes-Hoyt J, Alhusen J, Hanson GC, Perrin NA. Longitudinal Impact of the myPlan App on Health and Safety Among College Women Experiencing Partner Violence. J Interpers Violence. 2022 Jul;37(13-14):NP11436-NP11459. doi: 10.1177/0886260521991880. Epub 2021 Feb 12.
- Results publication: PubMed 37738092Lin Z, Cheng L, Han X, Wang H, Liao Y, Guo L, Shi J, Fan B, Teopiz KM, Jawad MY, Zhang H, Chen Y, Lu C, McIntyre RS. The Effect of Internet-Based Cognitive Behavioral Therapy on Major Depressive Disorder: Randomized Controlled Trial. J Med Internet Res. 2023 Sep 22;25:e42786. doi: 10.2196/42786.
- Results publication: PubMed 38019579Chen D, Zhang H, Wu J, Xue E, Guo P, Tang L, Shao J, Cui N, Wang X, Chen L, Ye Z. Effects of an Individualized mHealth-Based Intervention on Health Behavior Change and Cardiovascular Risk Among People With Metabolic Syndrome Based on the Behavior Change Wheel: Quasi-Experimental Study. J Med Internet Res. 2023 Nov 29;25:e49257. doi: 10.2196/49257.
- Results publication: PubMed 37047862Sumra M, Asghar S, Khan KS, Fernandez-Luna JM, Huete JF, Bueno-Cavanillas A. Smartphone Apps for Domestic Violence Prevention: A Systematic Review. Int J Environ Res Public Health. 2023 Mar 23;20(7):5246. doi: 10.3390/ijerph20075246.
- Results publication: PubMed 17872937Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007 Dec;19(6):349-57. doi: 10.1093/intqhc/mzm042. Epub 2007 Sep 14.
- Results publication: PubMed 37902465Li Y, Rhee H, Bullock LFC, McCaw B, Bloom T. Self-Compassion, Health, and Empowerment: A Pilot Randomized Controlled Trial for Chinese Immigrant Women Experiencing Intimate Partner Violence. J Interpers Violence. 2024 Apr;39(7-8):1571-1595. doi: 10.1177/08862605231207624. Epub 2023 Oct 30.
- Results publication: PubMed 15384454Chan KL. Correlates of wife assault in Hong Kong Chinese families. Violence Vict. 2004 Apr;19(2):189-201. doi: 10.1891/vivi.19.2.189.64104.
- Results publicationBarbara MB, S. SM, H. PW. Validating the Beck Depression Inventory-II for Hong Kong Community Adolescents. International Journal of Testing. 2004;4(3):199-216. doi:10.1207/s15327574ijt0403_1
- Results publication: PubMed 16101604Tiwari A, Leung WC, Leung TW, Humphreys J, Parker B, Ho PC. A randomised controlled trial of empowerment training for Chinese abused pregnant women in Hong Kong. BJOG. 2005 Sep;112(9):1249-56. doi: 10.1111/j.1471-0528.2005.00709.x.
- Results publication: PubMed 33504670Tiwari A, Fong DYT, Yuen FKH, Fung HYK, Pang POY, Wong JYH. Purpose-built intervention for mental health of Mainland Chinese immigrant women survivors of intimate partner violence: a randomised controlled trial (abridged secondary publication). Hong Kong Med J. 2020 Dec;26 Suppl 8(6):7-9. No abstract available.
- Results publicationBroadhurst R, Bouhours B, Bacon-Shone J. Hong Kong the international violence against women survey: final report of the 2006 Hong Kong IVAWS. 2012. doi.org/10.2139/ssrn.2076994.
- Individual participant dataSharing planned: No
Related trials for Domestic Violence
RecruitingObservational study
Self-Dehumanization and Hesitation to Report Domestic Violence
Domestic Violence
Active, not recruiting
Community Resiliency Collective Efficacy Intervention
Violence, Physical, Violence, Non-accidental
Enrolling by invitation
Evaluation of a Trauma-Informed Partner Violence Intervention Program
Domestic Violence, Post Traumatic Stress Disorder
Not yet recruiting
Metacognitive Interpersonal Therapy for Male Intimate Partner Violence Perpetrators With Personality Disorders
Intimate Partner Violence, Personality Disorders
RecruitingObservational study
Evaluation of the Impact on Mental and Physical Health of Caring for Women Who Are Victims of Sexual and Gender-based Violence, Using a Coordinated Multidisciplinary Approach in Women's Centres or Traditional Health Centres.
Domestic and/or Sexual Violence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing WOMEN Health programme in people with Domestic Violence and Mental Health Wellness 1, run by The University of Hong Kong at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Quanlei Li (+852 39177577, qli1@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility and acceptability of the WOMEN Health programme (time frame: Week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07405528, which also lists 12 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026.